Live Life without Diabetes

**愿景*最终的愿景是看到一个没有与生活方式有关的、可预防的2型糖尿病及其相关并发症的世界，这些并发症往往对人们的生活、朋友和家人造成毁灭性的影响。这包括疾病造成的身体和心理代价，以及对个人、社会和国家造成的长期经济代价。虽然这是我们的愿景，但我们的目标在短期和中期仍然植根于现实。**关键目标*生活无糖尿病项目有一个明确的目标，即为参加该计划的人实现糖尿病缓解(即非糖尿病)。基于其他类似的项目，我们估计50%的参与计划的患者有能力实现糖尿病和糖尿病前期的完全缓解(第一年的正常HbA1c血液水平，这是检查糖尿病水平的血液测试)，并在未来的管理中持续缓解和逆转患者的长期教育和知识库增长。**主要关注领域*项目主任目前正在与伦敦中北部CCG的樱草山外科合作，目标是在手术中高达50%的患者实现糖尿病缓解。目标是让200名患者实现糖尿病缓解，或者如果他们是糖尿病前期患者，则达到非糖尿病状态。(总共有427名患者，占全科医生人口的6%，患有糖尿病前期或2型糖尿病)。*为了实现该计划的可重复性和可扩展性，正在申请赠款资金，将该计划部分数字化，以便更广泛和未来的受众能够获得该计划，他们将始终如一地需要这种支持以改善他们的健康结果。*该计划目前将以小组研讨会的形式运行，在12周内进行高强度的活动，并密切跟踪身体健康结果。但我们需要产品的数字化，以便可以在更大的范围内衡量和重复预期的成功，以及在NHS内竞争合同的能力(例如，糖尿病预防计划和2型糖尿病缓解计划)*资金也将增加可用于开发和交付的人员；允许更多的患者在最初12个月内使用该产品，首先是全科医生，在卡姆登的实践中创建一个清晰的商业案例，并结合临床专业知识，旨在创建一种能够在NHS、私营部门和全球范围内大规模交付的产品。

**Vision*** The ultimate vision is to see a world without lifestyle-related, preventable type 2 diabetes, and its associated complications and often devastating impact on people's lives, friends and families. This includes the physical and psychological cost of the disease, and long-term financial costs to individuals, societies and nations. While this is the vision our objectives remain rooted in reality in the short and medium term.**Key Objectives*** The Live Life without Diabetes project has a clear aim to achieve Diabetes remission (i.e. not diabetic) for those who are on the program. Based on other similar projects we estimate an ability for 50% of those who enter the program to achieve complete diabetes and pre-diabetes remission (normal Hba1c blood levels at year 1 which is the blood test to check for diabetes levels) with sustained remission and reversal and long-term education and knowledge base growth from patients in their future management.**Main areas of focus*** The project director is currently working with Primrose Hill Surgery in North Central London CCG with an aim to achieve Diabetes remission in up to 50% of the patients in the surgery. The aim for 200 patients to achieve diabetes remission, or to reach non-diabetic status if they were pre-diabetic. (In total there are 427 patients -- 6% of the GP practice population with pre-diabetes or type 2 diabetes).* To achieve repeatability and scalability of the program, grant funding is being requested to part digitalise the program so it is accessible to a wider and future audience who will invariably need this support to improve their health outcomes.* The program will currently be run as group workshops with high intensity over 12 weeks and close follow up of physical health outcomes, but we require digitalisation of the product so the intended successes can be measured and repeated on a larger scale and the ability to compete for contracts within the NHS (e.g. Diabetes Prevention Program and programs for type 2 diabetes remission)* Funding would also increase staffing available for development and delivery; allow more patients to access the product in the first 12 months initially GP across practices in Camden and create a clear business case alongside clinical expertise with an aim to create a product that is able to deliver at scale across the NHS, private sectors and worldwide.